Company: EVGN
Filing Date: 2025-03-27
Form Type: 20-F
Source: 0001178913-25-001092
Chunk: 230

Company: Evogene Ltd.
Filing Date: 2025-03-27
Form: 20-F
Item: Item 7
Chunk 230
---

ITEM 7.   MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS
-----------------------------------------------------------
A.          Major Shareholders
 
The following table sets forth information with respect to the beneficial ownership of our shares as of March 17, 2025 (unless otherwise indicated) by: (i) each of our directors and executive officers, individually; and (ii) all of our executive officers and directors, as a group. There is no person or entity known by us to own beneficially more than 5% of our outstanding shares.
 
The beneficial ownership of ordinary shares is determined in accordance with the rules of the SEC, and generally includes any ordinary shares over which a person exercises sole or shared voting or investment power, or the right to receive the economic benefit of ownership. For purposes of the table below, we deem shares subject to warrants and options that are currently exercisable or exercisable within 60 days of March 17, 2025, and RSUs that are currently vested or will become vested within 60 days of March 17, 2025, to be outstanding and to be beneficially owned by the person holding the warrants or options for the purposes of computing the percentage ownership of that person, but we do not treat them as outstanding for the purpose of computing the percentage ownership of any other person.
 
The percentage of shares beneficially owned by any shareholder has been calculated based on 6,672,173 ordinary shares outstanding as of March 17, 2025. Unless otherwise indicated below, to our knowledge, all persons named in the table have sole voting and investment power with respect to their shares, except to the extent that authority is shared by spouses under community property laws.
 
Unless otherwise noted below, each shareholder’s address is c/o Evogene Ltd., 13 Gad Feinstein Street, Park Rehovot, Rehovot 7638517, Israel. The shareholders listed below (including our directors and executive officers) do not have any different voting rights than any of our other shareholders. We know of no arrangements that would, at a subsequent date, result in a change of control of our company. A description of any material relationship that our principal shareholders have had with us or any of our predecessors or affiliates within the past year is included under “Item 7. Major Shareholders and Related Party Transactions—B. Related Party Transactions.”
 

                                                                               Shares Beneficially Held                  
-------------------------------------------------------------------------------------------------------------------------
Name of Beneficial Owner                                                 Number                   Percentage of Class    
Executive Officers and Directors                                                                                         
Mr